Your browser doesn't support javascript.
loading
Contribution of Chinese herbal medicine in the treatment of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of randomized controlled trials.
Jin, Di; Wang, Jing; Xue, Jiaojiao; Zhao, Yunyun; Yan, Guanchi; Li, Xiangyan; Wang, Xiuge.
Afiliação
  • Jin D; The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.
  • Wang J; The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.
  • Xue J; College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
  • Zhao Y; College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
  • Yan G; College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
  • Li X; Jilin Ginseng Academy, Key Laboratory of Active Substances and Biological Mechanisms of Ginseng Efficacy, Ministry of Education, Jilin Provincial Key Laboratory of Bio-Macromolecules of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
  • Wang X; The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.
Phytother Res ; 37(3): 1015-1035, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36382689

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Medicamentos de Ervas Chinesas / COVID-19 Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Phytother Res Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Medicamentos de Ervas Chinesas / COVID-19 Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Phytother Res Ano de publicação: 2023 Tipo de documento: Article